Navigation Links
Second ISPE-FDA Event Attracts Top Names, Features Release of Drug Shortage Survey Results

TAMPA, Fla., April 16, 2013 /PRNewswire/ -- ISPE announced today that it will hold its second annual Redefining the "C" in CGMP conference, 11 – 13 June in Baltimore, Maryland USA. Themed "Ensuring a Reliable Supply of Quality Medicines," the event will feature strategic education on issues of interest to industry leaders and global regulatory officials focused on quality systems, processes and technology utilization that drive quality enhancements that support a reliable drug supply.

"This event is where industry and regulators must come together to share their views on contemporary regulatory issues and solutions," said ISPE President and CEO Nancy Berg . "The sessions, case studies and workshops will be focused on how great companies are establishing and sustaining a culture of quality through contemporary quality management strategies, new methods and technologies, metrics and more effective approaches to integrating suppliers into quality systems."

The event will feature top speakers from the pharmaceutical industry and regulatory agencies, including:

  • Howard Sklamberg , Director, Office of Compliance, US FDA
  • Andy Skibo , Regional Vice President, Biologics-Supply, MedImmune/AstraZeneca
  • Gerald Heddell , Director of Inspection, Enforcement and Standards, MHRA, UK
  • John Pinion , Senior Vice President, Quality/Compliance, Genentech, Inc.
  • Zena Kaufman , Senior Vice President, Global Quality, Hospira
  • Cindy Salamon , Vice President, Global Quality Services, Bristol-Myers Squibb
  • Carol Bye , Vice President, Pharmaceutical Sciences Quality Operations, Pfizer, Inc.

Education content will focus on providing attendees with new insights and executable action plans to help resolve challenges related to quality leadership, quality metrics, CMO quality management, flexible manufacturing and other hot topics related to product quality and patient safety. The event will also feature the first public release of key data resulting from the ISPE Drug Shortage Survey, with an expert industry team providing commentary on the ISPE research, the impact of drug shortages and potential solutions. A Meet the Press session will feature a joint regulatory and industry panel answering questions from recognized pharma media experts on strategies for industry and regulatory collaboration, as well as compliance and product quality issues.

More information on the Redefining the "C" in CGMP Conference, including complete education details and registration information, is available at

About ISPE
ISPE, the International Society for Pharmaceutical Engineering, is the world's largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Tampa, Florida, USA and offices in Brussels, Belgium, Singapore and Shanghai, China. Visit for more information.

For more information contact:
Danielle Hould
ISPE Communications Manager
Tel: +1-813-960-2105, ext. 277

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Rochester Medical Announces Second Quarter 2013 Earnings Conference Call Thursday, April 25, 2013
2. Span-America Medical Systems To Release Second Quarter Results On May 1, 2013
3. BD Announces Live Webcast Of Second Fiscal Quarter Earnings Conference Call
4. VG Life Sciences Reports Positive Safety Results from Second Cohort Enrollment in Solid Tumor Clinical Trial
5. Hill-Rom Holdings, Inc. Hosts Fiscal 2013 Second Quarter Earnings Conference Call and Webcast
6. Surveyed U.S. Physicians Indicate That Xarelto and Apixaban Will Benefit From the Lack of Use of a Fast-Acting Injectable Anticoagulant in the Treatment and Secondary Prophylaxis of Deep Vein Thrombosis/Pulmonary Embolism
7. Hologic to Release Second Quarter Fiscal 2013 Operating Results on Monday, May 6, 2013
8. Despite the Recent Availability of Xtandi, Zytiga Continues to Dominate the Second-Line Metastatic Castrate-Resistant Prostate Cancer Setting, According to Surveyed U.S. Oncologists and Urologists
9. United Therapeutics Announces Receipt Of Second Complete Response Letter For Oral Treprostinil NDA
10. Baxter And Halozyme Announce Positive Opinion For HyQvia For Treatment Of Primary And Secondary Immunodeficiencies In The European Union
11. Millennium Research Group Sponsors Case Competition at Western University for Second Year
Post Your Comments:
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)... CAMBRIDGE, Mass. , June 24, 2016 /PRNewswire/ ... the Spaulding Rehabilitation Network,s Dean Center for ... of Physical Medicine and Rehabilitation, MIT Hacking Medicine, ... Center for Innovation, today announced the five finalists ... Hackathon for Lyme disease.  More than 100 scientists, ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June ... -based mobile pulmonary function testing company, is now able to ... devices developed by ndd Medical Technologies , Inc. ... done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ... , can get any needed testing done in the comfort of ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
Breaking Medicine News(10 mins):